Emerging Tech
Small, focused innovators building tomorrow's breakthrough tech
Clone Emerging Tech
Copies this strategy's roster and target weights into a new fund in your account. Nothing is bought β you fund it and approve every trade yourself.
Thesis
Emerging Tech is a portfolio of micro- and small-cap companies working on technologies that have not yet been widely adopted or commercially proven, but that could have profound societal impact. The fund looks for focused specialists with defensible positioning, whether through intellectual property, regulatory head starts, proprietary data, unique manufacturing processes, or key customer relationships. The fund is deliberately vertical-agnostic, spanning areas such as biotech and pharmaceutical innovation, clean energy, AI infrastructure and compute efficiency, health tech, advanced materials, and space and satellite technology. Holdings are organized into two sleeves: a Core sleeve of names with solid fundamentals and early market traction, and a Breakout sleeve of higher-conviction names where the technology appears closer to an inflection point or a specific near-term catalyst is in view. By holding a diversified basket of these companies across multiple verticals, the strategy is built around the idea that transformative technology tends to emerge from small, dedicated teams working ahead of mainstream attention.
Track record
Rebased to 100 at inception, net of the strategy's trading β deposits and withdrawals don't distort it. Past performance is not indicative of future results.
Roster (42)
Target weights that define the strategy β what a clone starts from.
| Ticker | Company | Sleeve | Target |
|---|---|---|---|
| BFLY | Butterfly Network, Inc. | Core | 3.00% |
| BKSY | BlackSky Technology Inc. | Core | 3.00% |
| PLSE | Pulse Biosciences, Inc. | Breakout | 3.00% |
| PSNL | Personalis, Inc. | Core | 3.00% |
| SLDP | Solid Power, Inc. | Breakout | 3.00% |
| LWLG | Lightwave Logic, Inc. | Breakout | 2.92% |
| ALLO | Allogene Therapeutics, Inc. | Breakout | 2.83% |
| BIOA | BioAge Labs, Inc. | Breakout | 2.83% |
| TENX | Tenax Therapeutics, Inc. | Breakout | 2.83% |
| ANNX | Annexon, Inc. | Breakout | 2.74% |
| CMPS | Compass Pathways plc | Breakout | 2.74% |
| ABSI | Absci Corp. | Breakout | 2.69% |
| NNE | NANO Nuclear Energy Inc. | Breakout | 2.59% |
| AEVA | Aeva Technologies, Inc. | Breakout | 2.56% |
| AMPX | Amprius Technologies, Inc. | Breakout | 2.56% |
| EOSE | Eos Energy Enterprises | Breakout | 2.56% |
| NRGV | Energy Vault Holdings, Inc. | Breakout | 2.56% |
| BBAI | BigBear.ai Holdings, Inc. | Breakout | 2.56% |
| INDI | indie Semiconductor, Inc. | Core | 2.56% |
| IPX | IperionX Limited | Breakout | 2.56% |
| LPTH | LightPath Technologies, Inc. | Core | 2.56% |
| PRCT | PROCEPT BioRobotics Corporation | Core | 2.56% |
| SATL | Satellogic Inc. | Core | 2.56% |
| SDGR | SchrΓΆdinger, Inc. | Core | 2.56% |
| SGHT | Sight Sciences, Inc. | Core | 2.56% |
| OSS | One Stop Systems, Inc. | Breakout | 2.52% |
| LYEL | Lyell Immunopharma, Inc. | Breakout | 2.44% |
| BIOX | Bioceres Crop Solutions Corp. | Core | 2.33% |
| SANA | Sana Biotechnology, Inc. | Breakout | 2.28% |
| CRML | Critical Metals Corp. | Core | 2.28% |
| CGEN | Compugen Ltd. | Core | 2.28% |
| RXRX | Recursion Pharmaceuticals, Inc. | Breakout | 2.19% |
| NB | NioCorp Developments Ltd. | Breakout | 2.05% |
| AIP | Arteris, Inc. | Core | 2.02% |
| PROK | ProKidney Corp. | Breakout | 1.82% |
| QSI | Quantum-Si Incorporated | Breakout | 1.82% |
| SERA | Sera Prognostics, Inc. | Core | 1.53% |
| SPIR | Spire Global, Inc. | Core | 1.53% |
| BCAX | Bicara Therapeutics Inc. | Breakout | 1.33% |
| SION | Sionna Therapeutics, Inc. | Breakout | 1.33% |
| STOK | Stoke Therapeutics, Inc. | Breakout | 1.33% |
| LUNG | Pulmonx Corporation | Core | 1.02% |